Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2020-08-14 Earnings Release
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
Q2 and H1/2020: Tangible positive impact of restructuring on aap performance in challenging COVID-19 times
Earnings Release Classification · 100% confidence The document text explicitly details financial results for 'Q2 and H1/2020' (Second Quarter and First Half of 2020), including sales figures, EBITDA, gross margins, and cash flow. It presents detailed tables comparing these figures to the previous year (Q2/2019 and H1/2019). This content structure—comprehensive period-specific financial performance review, including management commentary and outlook—is characteristic of an Interim/Quarterly Report (IR). It is not merely an Earnings Release (ER) which typically provides only highlights, nor is it the full Annual Report (10-K). The document also mentions financing activities and restructuring progress, which are common components of a detailed interim report. H1 2020
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and the German regulatory phrase "DGAP-DD: aap Implantate AG english" which stands for Directors' Dealings notification. It details transactions by a person discharging managerial responsibilities (Jürgen Krebs) and a person closely associated with them, concerning financial instruments linked to shares. This directly matches the definition for Director's Dealing (DIRS). The document length is short (2407 chars), but the content is the primary disclosure itself, not an announcement of a report.
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction involving a person closely associated with a member of the administrative body (Dr. Natalie Krebs) and the issuer (aap Implantate AG). This directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'. The document length is short (2374 chars), but the content is the primary disclosure itself, not an announcement of a report, so the RPA/RNS rule does not apply here.
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document explicitly states 'Directors’ Dealings' in the header and contains detailed information regarding a transaction by a 'person closely associated' with a member of the managing body (Rubino Di Girolamo). The structure and content align perfectly with regulatory disclosures concerning insider transactions by management or closely associated persons. This maps directly to the 'Director's Dealing' category.
2020-08-14 English
DGAP-DD: aap Implantate AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a section labeled 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details a transaction involving a specific individual (Biense Visser, Member of the administrative or supervisory body) and the issuer (aap Implantate AG). This content directly matches the definition for Director's Dealing reports.
2020-08-14 English
Halbjahresfinanzbericht
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Halbjahresfinanzbericht 2020' (Half-Year Financial Report 2020) for aap Implantate AG. It contains comprehensive financial tables (Umsatz, EBITDA, Cash-Flow, Balance Sheet) for the period 01.01.2020 to 30.06.2020, along with a detailed management discussion (Vorwort des Vorstandes) regarding restructuring, COVID-19 impact, and future outlook. Since it provides substantive financial statements and analysis for an interim period, it is classified as an Interim/Quarterly Report. H1 2020
2020-08-14 German

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.